US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.6011
- -0.0019-0.32%
Close Dec 2 16:00 ET
- 0.6011
- 0.00000.00%
Post 20:01 ET
2.94MMarket Cap-9P/E (TTM)
0.6100High0.5840Low48.78KVolume0.6029Open0.6030Pre Close29.35KTurnover1.00%Turnover RatioLossP/E (Static)4.89MShares10.234052wk High2.76P/B2.93MFloat Cap0.361152wk Low--Dividend TTM4.88MShs Float130156.1979Historical High--Div YieldTTM4.31%Amplitude0.3610Historical Low0.6010Avg Price1Lot Size
NovaBay Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -219.04%-2.06M | 66.12%-578K | -32.43%-1.57M | 37.92%-4.13M | 51.03%-592K | 61.75%-646K | -0.41%-1.71M | 42.29%-1.19M | 27.61%-6.65M | 72.00%-1.21M |
| Net income from continuing operations | 10.42%-1.21M | 8.28%-1.59M | -129.74%-3.09M | 9.13%-9.64M | 36.46%-5.21M | -894.85%-1.35M | 19.81%-1.73M | -1,111.71%-1.35M | -82.14%-10.61M | -5,093.67%-8.21M |
| Operating gains losses | --0 | --232K | --606K | 99.43%-20K | 94.98%-49K | --0 | ---- | ---- | 23.42%-3.52M | 78.85%-976K |
| Depreciation and amortization | 0.00%95K | 16.99%179K | -7.69%12K | -57.97%203K | -147.15%-58K | -20.17%95K | 27.50%153K | -89.26%13K | 305.88%483K | 41.38%123K |
| Other non cash items | -78.10%145K | --311K | --783K | 401.25%1.69M | 266.96%571K | --662K | ---- | ---- | ---561K | ---342K |
| Change In working capital | -891.96%-1.11M | 133.77%230K | -18.57%57K | 40.71%750K | 13.39%1.47M | 88.48%-112K | -474.18%-681K | 191.67%70K | 1,502.63%533K | 1,723.75%1.3M |
| -Change in receivables | -111.26%-157K | 125.58%187K | -121.60%-54K | 498.03%1.21M | 88.13%301K | 234.69%1.39M | -160.82%-731K | 139.56%250K | -167.48%-305K | -15.34%160K |
| -Change in inventory | 299.12%227K | -3,600.00%-37K | -33.75%-107K | 358.06%560K | 19.65%755K | 57.30%-114K | 93.75%-1K | 85.84%-80K | 10.70%-217K | 434.75%631K |
| -Change in prepaid assets | -143.03%-71K | 405.26%116K | -155.56%-115K | -21.10%172K | 662.50%90K | 94.12%165K | -130.89%-38K | -273.08%-45K | 519.23%218K | -155.17%-16K |
| -Change in payables and accrued expense | 32.03%-989K | -37.92%149K | 516.22%308K | -273.61%-1.16M | -75.70%131K | -1,965.38%-1.46M | 121.20%240K | -106.26%-74K | 509.20%667K | 226.82%539K |
| -Change in other current assets | -260.00%-18K | -43.10%-83K | 60.38%85K | 128.07%400K | 301.96%410K | -101.79%-5K | -147.54%-58K | 102.75%53K | -5,800.00%-1.43M | 142.32%102K |
| -Change in other current liabilities | -6.19%-103K | -9.68%-102K | -76.47%-60K | -127.46%-438K | -82.91%-214K | 13.39%-97K | 20.51%-93K | -101.75%-34K | 2,898.25%1.6M | -146.80%-117K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -219.04%-2.06M | 66.12%-578K | -32.43%-1.57M | 37.92%-4.13M | 51.03%-592K | 61.75%-646K | -0.41%-1.71M | 42.29%-1.19M | 27.61%-6.65M | 72.00%-1.21M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.00%-2K | 0.00%-2K | 8,315.38%1.07M | 83.04%-19K | -3K | 98.75%-1K | 75.00%-2K | 45.83%-13K | 99.07%-112K | 0 |
| Net PPE purchase and sale | -100.00%-2K | 0.00%-2K | 84.62%-2K | 83.04%-19K | ---3K | 98.75%-1K | 75.00%-2K | 45.83%-13K | -115.38%-112K | --0 |
| Net business purchase and sale | --0 | --0 | --1.07M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.00%-2K | 0.00%-2K | 8,315.38%1.07M | 83.04%-19K | ---3K | 98.75%-1K | 75.00%-2K | 45.83%-13K | 99.07%-112K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 462.05%2.09M | -119.58%-492K | -597K | -58.77%1.91M | -100.86%-26K | -133.88%-577K | 2.51M | 0 | -72.40%4.63M | -79.49%3.04M |
| Net issuance payments of debt | -36.92%-790K | -122.16%-622K | ---578K | 1,553.33%1.53M | ---704K | ---577K | --2.81M | --0 | -200.00%-105K | --0 |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -79.64%3.04M | ---- |
| Proceeds from stock option exercised by employees | --21K | ---- | ---- | -66.82%565K | --565K | --0 | ---- | ---- | --1.7M | --0 |
| Net other financing activities | --0 | ---96K | ---19K | ---181K | --113K | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 462.05%2.09M | -119.58%-492K | ---597K | -58.77%1.91M | -100.86%-26K | -133.88%-577K | --2.51M | --0 | -72.40%4.63M | -79.49%3.04M |
| Net cash flow | ||||||||||
| Beginning cash position | -74.83%1.23M | -44.87%2.3M | -38.32%3.61M | -26.73%5.85M | -9.08%3.66M | 19.29%4.87M | -28.02%4.17M | -26.73%5.85M | -35.79%7.98M | -57.70%4.02M |
| Current changes in cash | 102.76%26K | -260.48%-1.07M | 19.52%-1.31M | -5.02%-2.24M | -118.73%-342K | -1,327.27%-942K | 139.13%668K | 25.71%-1.62M | 52.05%-2.13M | 219.82%1.83M |
| End cash Position | -65.72%1.25M | -74.83%1.23M | -44.87%2.3M | -38.32%3.61M | -38.32%3.61M | -9.08%3.66M | 19.29%4.87M | -28.02%4.17M | -26.73%5.85M | -26.73%5.85M |
| Free cash flow | -218.86%-2.06M | 66.04%-580K | -31.17%-1.57M | 38.66%-4.15M | 50.79%-595K | 63.43%-647K | -0.06%-1.71M | 42.34%-1.2M | 26.81%-6.77M | 72.05%-1.21M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data